Vitamin Blue (VTMB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VTMB Annual Balance Sheets →
Quarterly balance sheet trends provide context on Vitamin Blue's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2013)
(Jun 30 2013) (Mar 31 2013) (Dec 31 2012) (Sep 30 2012)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Accounts receivable0.01
Inventories0.01
Other Current Assets0.00
Prepaid Expense, Current AS0.01
Total Current Assets0.03
Equipment/Property/Plant Net0.00
Prepaid Expense, Noncurrent, Total PR0.01
Other Assets, Noncurrent0.00
Total Assets0.04
Liabilities
Accounts Payable, Current AC0.10
Accrued Liabilities, Current0.04
Derivative Liability LI0.41
Convertible Notes Payable, Current NO0.19
Other Liabilities, Current0.20
Total Current Liabilities0.93
Long-term debt0.11
Total Long-term Debt0.11
Total Liabilities0.93
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock1.15
Retained Earnings / Accumulated Deficit-2.12
Other Equity0.00
Common Stockholder's Equity-0.89
Total Stockholder's Equity-0.89
Liabilities & Stockholder's Equity0.04
4 historic quarters locked

Sign in to unlock the full Vitamin Blue balance sheet history.

About VTMB Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.